ESC 365 - Exploring the role of novel CETP inhibitors in lipid management

Open Access

Exploring the role of novel CETP inhibitors in lipid management

Session: Role of CETP inhibitors in cardiovascular risk reduction: will lessons from the past lead to future success?

Topic: Lipid-Lowering Agents

Speaker: Professor R. Mehran (New York, US)

Sponsored by PACE-CME – Supported by an unrestricted educational grant from Menarini and NewAmsterdam Pharma

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Professor Roxana Mehran

Icahn School of Medicine at Mount Sinai, New York (United States of America)

53 presentations

12 followers

4 more presentations in this session

Introduction

Speaker: Professor E. Stroes (Amsterdam, NL)

Unmet needs in lowering LDL-c: barriers to goal attainment and need for innovative targets

Speaker: Professor S. Nicholls (Melbourne, AU)

New insights on CETP inhibitors from genetic research and clinical trials

Speaker: Professor J. Kastelein (Amsterdam, NL)

Discussion

Speaker: Professor E. Stroes (Amsterdam, NL) Professor S. Nicholls (Melbourne, AU) Professor J. Kastelein (Amsterdam, NL) Professor R. Mehran (New York, US)

Access the full session

Role of CETP inhibitors in cardiovascular risk reduction: will lessons from the past lead to future success?

Speakers: Professor R. Mehran, Professor E. Stroes, Professor S. Nicholls, Professor J. Kastelein, Professor E. Stroes...

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources